Serena Williams & Aly Raisman Partner With Ubrelvy For Migraine Awareness Month

This month marks the Migraine and Headache Awareness Month, and several people worldwide, including the famous Serena Williams and Aly Raisman, strive for the diseases to be more recognized. 

The influential sportswomen recently shared a collaborative video with the drug company Ubrelvy on their Instagram pages, respectively, openly narrating their migraine and Ubrelvy experience.

Ubrelvy is a "prescription medicine" for migraine attacks in U.S. adults only and not for migraine prevention. Additionally, the most typical side effects associated with the product are nausea and tiredness.

Raisman revealed in the video that when she started to learn more about migraines from friends, social media posts, and research, she realized the power of sharing one's experiences.

On the other hand, Williams used to have headaches but did not initially think they were migraines till she grew older. Her migraine was like a grinding headache at her temple and sometimes at the front of her head.

After every competition and before retirement, Raisman used to have terrible migraines as she wore her hair in a tight bun with about "eighteen elastics" in her hair. She classified the condition as "just a hair headache" at the time.

Even after taking her hair down, she still felt the headache and the back of her scalp was "so sensitive," which she said was a migraine symptom, but she had no idea then.

Williams butted in, saying there were times she had a migraine while playing on the court, but she could not just stop the tournament, so she usually had to endure it till the end.

The famed athletes then admitted that their career made them "power and push through" irrespective of how bad the headaches got but with Ubrelvy, they can still power through without feeling any side effects.

Using Ubrelvy is "great and powering" for both of them as they can now understand what's happening in their body and be more self-aware of migraine symptoms.

The video ended with a brief description of the drug, including its common side effects and those who should not take it.

Williams wrote below the clip, "Even at the top of our games, @alyraisman & I battled the same opponent for years - #migraine attacks. Like many people living with migraine, we just powered through the pain."

She continued, "That's why for Migraine and Headache Awareness Month, we're sharing our stories and teaming up to hit back with #UBRELVY."

The caption also showed there were risks associated with the product, meaning users have to consult their healthcare provider about the drug and whether it was right for them.

According to CHCW, headaches and migraines are part of the commonest "disorders of the human nervous system," as more than half of the adult population have had at least one headache in the past year.

The symptoms include unbearable migraines, dull and throbbing head discomfort, piercing cluster pain, neck aches and tension, nausea, and hypersensitivity to light, smell, and sounds.

When headaches and migraines are left untreated, they could lead to depression, isolation, and self-medication. However, occasional headaches are pretty common and usually do not require medical attention.

Williams will reportedly be returning to court tournaments as she will make a comeback in this year's Wimbledon, giving her a chance to achieve her 24th Grand Slam title.

As The Blast reported, Wimbledon announced the news via Twitter on June 14, 2022. The brief release read, "Our 7-time champion will return to Wimbledon as a wild card this summer for her 21st appearance."

Her said 21st appearance would come after taking a year break from the tournament and other competitions due to her injury during her first-round contest against Aliaksandra Sasnovich.

Viewers of the then-match held at the All-England Club saw the 40-year-old exiting the court while crying, and she took the much-needed extended break to get back on track.

Not to mention, her name was also not included in Wimbledon's women's singles entry list, released this month, leading fans to assume her hiatus would last longer.

Nevertheless, her supporters expressed their anticipation for the competition and could not wait to see the pro tennis player dominate the court as she always does.